683 Capital Management, LLC Soleno Therapeutics Inc Transaction History

683 Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.77 - $4.23 $708,000 - $1.69 Million	-400,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.64 - $3.85 $35,894 - $84,264	-21,887 Reduced 5.19%	400,000 $952,000
Q4 2019 Feb 14, 2020	SELL	$1.35 - $2.95 $198,720 - $434,240	-147,200 Reduced 25.87%	421,887 $1.24 Million
Q1 2019 May 15, 2019	SELL	$1.35 - $2.68 $371,283 - $737,067	-275,025 Reduced 32.58%	569,087 $1.17 Million
Q4 2017 Feb 14, 2018	BUY	$1.39 - $2.73 $1.17 Million - $2.3 Million	844,112	844,112 $1.52 Million

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.